- call +1-201-465-4211
- email sales@mrinsights.biz
Disruptive Behavior Disorders (DBD) is behavioral disorders characterized by hostile and defiant behaviors that children and adolescents direct towards others.
Scope of the Report:
The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, active involvement of NGO and government programs to increase awareness.
The global Disruptive Behavior Disorders (DBD) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Disruptive Behavior Disorders (DBD).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Disruptive Behavior Disorders (DBD) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Disruptive Behavior Disorders (DBD) market by product type and applications/end industries.
Market Segment by Companies, this report covers
Eli Lilly
Bionomics
Chelsea Therapeutics
Pfizer
Johnson & Johnson
DURECT
Novartis
McNeil Pharmaceuticals
Sunovion Pharmaceuticals
New River Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Conduct Disorder (CD)
Oppositional Defiant Disorder (ODD)
Market Segment by Applications, can be divided into
Hospitals and Clinics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Disruptive Behavior Disorders (DBD) Market Overview
1.1 Product Overview and Scope of Disruptive Behavior Disorders (DBD)
1.2 Classification of Disruptive Behavior Disorders (DBD) by Types
1.2.1 Global Disruptive Behavior Disorders (DBD) Revenue Comparison by Types (2017-2023)
1.2.2 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Types in 2017
1.2.3 Conduct Disorder (CD)
1.2.4 Oppositional Defiant Disorder (ODD)
1.3 Global Disruptive Behavior Disorders (DBD) Market by Application
1.3.1 Global Disruptive Behavior Disorders (DBD) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Disruptive Behavior Disorders (DBD) Market by Regions
1.4.1 Global Disruptive Behavior Disorders (DBD) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Disruptive Behavior Disorders (DBD) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Disruptive Behavior Disorders (DBD) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Disruptive Behavior Disorders (DBD) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Disruptive Behavior Disorders (DBD) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Disruptive Behavior Disorders (DBD) Status and Prospect (2013-2023)
1.5 Global Market Size of Disruptive Behavior Disorders (DBD) (2013-2023)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bionomics
2.2.1 Business Overview
2.2.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bionomics Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Chelsea Therapeutics
2.3.1 Business Overview
2.3.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.6 DURECT
2.6.1 Business Overview
2.6.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 DURECT Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.8 McNeil Pharmaceuticals
2.8.1 Business Overview
2.8.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sunovion Pharmaceuticals
2.9.1 Business Overview
2.9.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
2.10 New River Pharmaceuticals
2.10.1 Business Overview
2.10.2 Disruptive Behavior Disorders (DBD) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Disruptive Behavior Disorders (DBD) Market Competition, by Players
3.1 Global Disruptive Behavior Disorders (DBD) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Disruptive Behavior Disorders (DBD) Players Market Share
3.2.2 Top 10 Disruptive Behavior Disorders (DBD) Players Market Share
3.3 Market Competition Trend
4 Global Disruptive Behavior Disorders (DBD) Market Size by Regions
4.1 Global Disruptive Behavior Disorders (DBD) Revenue and Market Share by Regions
4.2 North America Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
4.3 Europe Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
4.5 South America Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
5 North America Disruptive Behavior Disorders (DBD) Revenue by Countries
5.1 North America Disruptive Behavior Disorders (DBD) Revenue by Countries (2013-2018)
5.2 USA Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
5.3 Canada Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
5.4 Mexico Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
6 Europe Disruptive Behavior Disorders (DBD) Revenue by Countries
6.1 Europe Disruptive Behavior Disorders (DBD) Revenue by Countries (2013-2018)
6.2 Germany Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
6.3 UK Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
6.4 France Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
6.5 Russia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
6.6 Italy Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue by Countries
7.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue by Countries (2013-2018)
7.2 China Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
7.3 Japan Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
7.4 Korea Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
7.5 India Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
8 South America Disruptive Behavior Disorders (DBD) Revenue by Countries
8.1 South America Disruptive Behavior Disorders (DBD) Revenue by Countries (2013-2018)
8.2 Brazil Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
8.3 Argentina Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
8.4 Colombia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Disruptive Behavior Disorders (DBD) by Countries
9.1 Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
9.3 UAE Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
9.4 Egypt Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
9.6 South Africa Disruptive Behavior Disorders (DBD) Revenue and Growth Rate (2013-2018)
10 Global Disruptive Behavior Disorders (DBD) Market Segment by Type
10.1 Global Disruptive Behavior Disorders (DBD) Revenue and Market Share by Type (2013-2018)
10.2 Global Disruptive Behavior Disorders (DBD) Market Forecast by Type (2018-2023)
10.3 Conduct Disorder (CD) Revenue Growth Rate (2013-2023)
10.4 Oppositional Defiant Disorder (ODD) Revenue Growth Rate (2013-2023)
11 Global Disruptive Behavior Disorders (DBD) Market Segment by Application
11.1 Global Disruptive Behavior Disorders (DBD) Revenue Market Share by Application (2013-2018)
11.2 Disruptive Behavior Disorders (DBD) Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Others Revenue Growth (2013-2018)
12 Global Disruptive Behavior Disorders (DBD) Market Size Forecast (2018-2023)
12.1 Global Disruptive Behavior Disorders (DBD) Market Size Forecast (2018-2023)
12.2 Global Disruptive Behavior Disorders (DBD) Market Forecast by Regions (2018-2023)
12.3 North America Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2018-2023)
12.4 Europe Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2018-2023)
12.6 South America Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Disruptive Behavior Disorders (DBD) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Disruptive Behavior Disorders (DBD) Picture
Table Product Specifications of Disruptive Behavior Disorders (DBD)
Table Global Disruptive Behavior Disorders (DBD) and
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
